NewAmsterdam Pharma Company
NAMS
#4361
Rank
HK$13.49 B
Marketcap
HK$122.91
Share price
-12.17%
Change (1 day)
-26.68%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of December 2024 : HK$6.48 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company has HK$6.48 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$6.47 B143.57%
2023-12-31HK$2.65 B-32.17%
2022-12-31HK$3.92 B638.47%
2021-12-31HK$0.53 B475.79%
2020-12-31HK$92.19 M